CompoundList
Sign in
Murcko scaffold

N-3-Piperidinyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine scaffold

72 chemicals on CompoundList share this ring system.

Rings
3
Scaffold atoms
16
Chemicals
72
With full pages
9
Scaffold SMILES

c1nc(NC2CCCNC2)c2cc[nH]c2n1

A Bemis-Murcko scaffold is what remains of a molecule when every side chain is removed: the rings and the chains that link them. Chemicals that share a scaffold often belong to the same compound series, which helps when you look for analogues, alternative suppliers or related building blocks.

Substructure search with this scaffoldOpen the N-3-Piperidinyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine page
Murcko scaffold c1nc(NC2CCCNC2)c2cc[nH]c2n1

Computed from the structures of the chemicals listed here. Stereo and charges are removed before the scaffold is taken.

Chemicals with this scaffold

Open one to see its structure, properties and suppliers.

Showing 1 to 48 of 72 chemicals

Racemic-tasocitinib chemical structure, C16H20N6O, CAS 344418-92-4
Racemic-tasocitinib
CAS 344418-92-4C16H20N6O
Tofacitinib chemical structure, C16H20N6O, CAS 477600-75-2
Tofacitinib
CAS 477600-75-2C16H20N6O
(3S,4R)-4-Methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile chemical structure, C16H20N6O, CAS 1092578-48-7
(3S,4R)-4-Methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile
CAS 1092578-48-7C16H20N6O
Tofacitinib citrate chemical structure, C22H28N6O8, CAS 540737-29-9
Tofacitinib citrate
CAS 540737-29-9C22H28N6O8
3,3,3-Trifluoro-1-[4-methyl-3-[methyl-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]propan-1-one chemical structure, C17H22F3N5O, CAS 344419-71-2
3,3,3-Trifluoro-1-[4-methyl-3-[methyl-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]propan-1-one
CAS 344419-71-2C17H22F3N5O
N-Methyl-N-[(3S,4S)-4-methyl-3-piperidyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine chemical structure, C13H19N5, CAS 384336-73-6
N-Methyl-N-[(3S,4S)-4-methyl-3-piperidyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 384336-73-6C13H19N5
(3S,4S)-Tofacitinib chemical structure, C16H20N6O, CAS 1092578-47-6
(3S,4S)-Tofacitinib
CAS 1092578-47-6C16H20N6O
N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine chemical structure, C13H19N5, CAS 477600-74-1
N-Methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 477600-74-1C13H19N5
F2Esf439P7 chemical structure, C16H20N6O, CAS 1314642-24-4
F2Esf439P7
CAS 1314642-24-4C16H20N6O
Epitofacitinib, (3R,4S)- chemical structure, C16H20N6O, CAS 1092578-46-5
Epitofacitinib, (3R,4S)-
CAS 1092578-46-5C16H20N6O
N-Methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine chemical structure, C13H19N5, CAS 1260614-73-0
N-Methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 1260614-73-0C13H19N5
Tofacitinib metabolite M2 chemical structure, C15H21N5O2, CAS 1243290-37-0
Tofacitinib metabolite M2
CAS 1243290-37-0C15H21N5O2
Tofacitinib impurity 257 chemical structure, C16H23N5O2, CAS 1011723-46-8
Tofacitinib impurity 257
CAS 1011723-46-8C16H23N5O2
1-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone chemical structure, C15H21N5O, CAS 477600-76-3
1-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)ethanone
CAS 477600-76-3C15H21N5O
(3S,4S)-Tofacitinib citrate chemical structure, C22H28N6O8, CAS 2174011-55-1
(3S,4S)-Tofacitinib citrate
CAS 2174011-55-1C22H28N6O8
(R)-N-Methyl-N-(piperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine chemical structure, C12H17N5, CAS 2085808-02-0
(R)-N-Methyl-N-(piperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 2085808-02-0C12H17N5
(3R,4R)-tert-Butyl 4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-carboxylate chemical structure, C18H27N5O2, CAS 1450663-24-7
(3R,4R)-tert-Butyl 4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-carboxylate
CAS 1450663-24-7C18H27N5O2
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride chemical structure, C13H20ClN5, CAS 1260590-51-9
N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine hydrochloride
CAS 1260590-51-9C13H20ClN5
N-Methyl-N-(piperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine chemical structure, C12H17N5, CAS 1616624-25-9
N-Methyl-N-(piperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 1616624-25-9C12H17N5
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride chemical structure, C13H21Cl2N5, CAS 1655430-59-3
N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride
CAS 1655430-59-3C13H21Cl2N5
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine (dihydrochloride) chemical structure, C13H21Cl2N5, CAS 2803420-48-4
N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine (dihydrochloride)
CAS 2803420-48-4C13H21Cl2N5
3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide chemical structure, C16H22N6O2, CAS 1675248-19-7
3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanamide
CAS 1675248-19-7C16H22N6O2
N-((3R,4R)-1,4-Dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine chemical structure, C14H21N5, CAS 2227197-38-6
N-((3R,4R)-1,4-Dimethylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
CAS 2227197-38-6C14H21N5
N-((3R,4R)-1,4-diMethylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine (Hydrochloride) chemical structure, C14H22ClN5, CAS 2803376-19-2
N-((3R,4R)-1,4-diMethylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine (Hydrochloride)
CAS 2803376-19-2C14H22ClN5